Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) and 10-valent pneumococcal conjugate vaccine (PCV10) are two recently approved vaccines for the active immunization against Streptococcus pneumoniae causing invasive pneumococcal disease in infants and children. PCV13 offers broader...

Full description

Saved in:
Bibliographic Details
Main Authors: Earnshaw, Stephanie R, McDade, Cheryl L, Zanotti, Giovanni, Farkouh, Raymond A, Strutton, David
Format: Artigo
Language:Inglês
Published: BioMed Central 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532329/
https://ncbi.nlm.nih.gov/pubmed/22530841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-101
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items